Product Description: Remternetug is a human immunoglobulin G1-kappa, anti-APP (amyloid beta A4 precursor protein) Aβ42 N3pGlu peptide monoclonal antibody. Remternetug recognizes a pyroglutamated form of Aβ that aggregates into amyloid plaques[1].
Applications: Neuroscience-Neurodegeneration
Formula: N/A
References: [1]Li-Kai Huang, et al. Clinical trials of new drugs for Alzheimer disease: a 2020-2023 update. J Biomed Sci. 2023 Oct 2;30(1):83.